Why Infrastructure and Industry Collaboration are Key to Australia’s Genomic Future
We are living in a transformative moment for healthcare. As InGeNA CEO Dr Erin Evans recently highlighted in the Herald Sun, we are moving away from a general approach and towards data-informed precision care. This shift promises to deliver truly individualised treatment, from diagnosis to prevention, but it requires us to be ready for the changes ahead.
The integration of artificial intelligence into genomics is already accelerating our ability to diagnose severe genetic conditions. What once took a decade of global effort can now be achieved in days. AI helps clinicians sift through millions of data points to find the specific genetic changes responsible for disease. This capability is vital for the estimated one in ten people who have a genetic disorder, many of whom face long waitlists or conditions that remain hidden until later in life.
However, realising this vision requires more than just new technology. It demands substantial investment in our national infrastructure, both from government and industry. We need high-performance computing capacity and secure data storage to handle the vast amounts of information generated by genomic sequencing. Furthermore, as Professor Daniel MacArthur noted in the article, Australia urgently needs sovereign data resources. Without data that represents our unique population, we risk building tools that work well for some but fail to serve the diverse communities living here.
This is where the power of a connected ecosystem becomes essential. No single organisation can solve these infrastructure and data challenges alone. InGeNA exists to bring together industry, research, and government to advocate for these critical investments. By joining the InGeNA network, members can help shape the regulations and systems that will allow these innovations to be safely and effectively embedded into clinical care.
We encourage you to read the full article in the Herald Sun to explore these insights further. It is an exciting time for our sector, and by working together, we can ensure Australia remains at the forefront of this medical revolution.